Oralni JAK inhibitor Eli Lilly Olumiant (baricitinib): 9,3 godine liječenja, uz dugoročnu dobru sigurnost!--1/2 - Znanje - Hefei Home Sunshine Pharmaceutical Technology Co., Ltd
Olumiant offers hope to patients with rheumatoid arthritis - Drug Discovery and Development